Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

UK postgraduate health students have limited understanding of alopecia, with many misconceptions, highlighting the need for better awareness.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

More severe alopecia areata can lower quality of life.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Alopecia Areata patients have low zinc and high copper levels.

Prachanna followed by Chirabilwa lepa is more effective for alopecia areata than Prachanna followed by Gunja lepa.

Children with alopecia areata often have vitiligo, allergic asthma, ADHD, and low vitamin B12 and ferritin levels.

Both treatments help hair regrowth, but Botulinum Toxin-A has fewer side effects.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Early diagnosis and multidisciplinary care, including orthopedic surgery, can prevent long-term disability in IFAP syndrome.

64 drugs can cause hair loss, needing better monitoring and updated labels.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Upadacitinib effectively treats severe alopecia areata and is safe.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Low serum ferritin is linked to hair loss in women.

Alopecia areata patients often have undetected thyroid issues, so routine thyroid screening is recommended.

Higher air pollution increases the risk of alopecia areata.

hUC-MSC secretome can help regrow hair in cases of hair loss.